Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 65 Show results per page	View Search Criteria \| Help With Results

Last Modified: 5/21/2007 First Published: 4/1/2002


1.		Phase III Randomized Controlled Trial of Allogeneic Cytotoxic T-Cell Immunotherapy Following Reduction of Immunosuppression in Solid Organ Transplant Patients With Epstein-Barr Virus-Associated B-Cell Lymphoproliferative Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				Any age				Other				CRUK-EBV-CTL LCMV-CTL, EU-20057, NCT00033475

Last Modified: 12/1/2002 First Published: 10/1/1998


2.		Phase I/II Study of HLA-Matched Peripheral Blood Mobilized Hematopoietic Progenitor Cell Transplantation Followed by Allogeneic T-cell Infusion as Adoptive Immunotherapy in Patients With Metastatic Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 to 60				NHLBI				NHLBI-98-H-0006 NCT00003552

Last Modified: 11/12/2007 First Published: 9/1/1999


3.		Phase I/II Pilot Study of Donor Th2 Cells for Prevention of Graft-Versus-Host Disease After Non-Myeloablative, HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematologic Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Supportive care, Treatment				Closed				18 to 75				NCI				NCI-99-C-0143 NCI-3491, 3491, NCT00019851

Last Modified: 7/12/2007 First Published: 6/1/2000


4.		Phase I/II Pilot Study of Fludarabine and Low-Dose Total Body Irradiation, Followed By Unrelated Donor Stem Cell Transplantation in Patients With Hematologic Malignancies or Renal Cell Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				Any age				NCI				FHCRC-1463.00 NCI-G00-1762, NCT00005799

Last Modified: 4/21/2005 First Published: 6/1/2000


5.		Phase I/II Study of Chemotherapy Followed by Donor Lymphocyte Infusion Plus Interleukin-2 in Patients With Relapsed Acute Myeloid or Lymphoid Leukemia After Allogeneic Peripheral Blood Stem Cell Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				Not specified				NCI				FHCRC-1380.00 NCI-H00-0057, NCT00005802

Last Modified: 11/13/2006 First Published: 6/1/2000


6.		Phase I/II Study of HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation After Nonmyeloablative Conditioning Therapy in Patients With Metastatic Renal Cell Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				Under 75				NCI				FHCRC-1495.00 NCI-G00-1790, NCT00005851

Last Modified: 7/12/2007 First Published: 9/1/2000


7.		Phase I/II Study of Mixed Hematopoietic Chimerism Induction With Fludarabine, Low Dose Total Body Irradiation, and Allogeneic Peripheral Blood Stem Cell Transplantation Followed By Immunosuppression With Cyclosporine and Mycophenolate Mofetil in Patients With Malignancies Treatable By Allogeneic Bone Marrow (Stem Cell) Transplantation (Summary Last Modified 03/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				Under 75				NCI				FHCRC-1533.00 NCI-H00-0062, NCT00006251

Last Modified: 7/12/2007 First Published: 4/1/2001


8.		Phase I/II Study of Low-Dose Radiotherapy and Fludarabine Followed By Allogeneic Peripheral Blood Stem Cell Transplantation, Mycophenolate Mofetil, and Cyclosporine in Patients With Hematologic Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Supportive care, Treatment				Closed				Under 75				NCI				FHCRC-1596.00 NCI-H01-0068, NCT00014235

Last Modified: 8/9/2004 First Published: 12/1/2001


9.		Phase I/II Study of a Nonmyeloablative Conditioning Regimen Comprising Fludarabine and Total Body Irradiation Followed By Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation in Patients With High-Risk Acute Lymphoblastic Leukemia in Complete Remission

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				75 and under				NCI				FHCRC-1586.00 NCI-H01-0080, NCT00027547

Last Modified: 7/12/2007 First Published: 12/1/2001


10.		Phase I/II Study of Low-Dose Total-Body Irradiation and Fludarabine Followed By Unrelated Donor Peripheral Blood Stem Cell Transplantation Using Enhanced Post-Grafting Immunosuppression in Patients With Hematologic Malignancies or Renal Cell Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				Any age				NCI				FHCRC-1641.00 NCI-H01-0081, NCT00027820

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute